|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ãâ½Ã 3°³¿ù¸¸¿¡ ¼¿ï´ë¡¤¾Æ»ê¡¤¼¼ºê¶õ½ºº´¿ø 'ÀÔ¼º' [Á¦¾à]
|
| 2016-02-11 11:46:31 |
±èµµ°æ±âÀÚ |
|
| µ¹·çÅ×±×¶óºñ¸£¸¦ Æ÷ÇÔÇÑ ÃÖÃÊÀÇ ´ÜÀÏÁ¤ º¹ÇÕ HIV Ä¡·áÁ¦ ¡®Æ®¸®¸ß¡¯ÀÌ Ãâ½Ã 3°³¿ù ¸¸¿¡ ¼¿ï´ëº´¿øÀ» ºñ·ÔÇÑ ¼¼ºê¶õ½ºº´¿ø, ¼¿ï¾Æ»êº´¿ø, ±¹¸³¾Ï¼¾ÅÍ µî Àü±¹ ÁÖ¿ä º´¿ø ¾àÁ¦À§¿øÈ¸ ½ÉÀÇ(Drug Committee, ÀÌÇÏ DC)¸¦ Åë°úÇß´Ù.11ÀÏ GSK¿¡ µû¸£¸é Æ®¸®¸ß(µ¹·çÅ×±×¶óºñ¸£ 50mg, ¾Æ¹ÙÄ«ºñ¸£ 600mg, ¶ó¹ÌºÎµò 300mg)ÀÌ DC¸¦ Åë°úÇÑ º´¿øÀº ¾à 30°÷À¸·Î °æºÏ´ëº´¿ø°ú °í´ë ¾È¾Ïº´¿ø, ±¹¸³Áß¾ÓÀÇ·á¿ø, ºÎ»ê´ëº´¿ø, ¼¿ï´ëº´¿ø, ¼¿ï¾Æ»êº´¿ø, ¼¼ºê¶õ½ºº´¿ø, Àü³²´ëº´¿ø, Ãæ³²´ë... |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|